Cost-effectiveness for imaging stable ischemic disease

Area of Science:

• Cardiology
• Health Economics
• Medical Imaging

Background:

• Stable ischemic heart disease is a significant cause of illness and death.
• Current diagnostic and management imaging modalities lack a clear cost-effective strategy.
• Evidence-based clinical studies are needed to guide cost-effective approaches.

Purpose of the Study:

• To review recent evidence-based clinical studies and trials.
• To suggest the most cost-effective approach for managing stable ischemic heart disease.
• To discuss the limitations of existing studies.

Main Methods:

• Review of recent evidence-based clinical studies and trials.
• Analysis of multicenter trial results.
• Development of a suggested cost-effective pathway for stable ischemic heart disease management.

Main Results:

• Optimal medical therapy is suggested as the most cost-effective strategy for appropriate coronary artery disease patients.
• Invasive coronary angiography or revascularization is recommended for non-responders or those with >/=50% left main stenosis.
• Stress cardiac magnetic resonance imaging is proposed for patients with non-diagnostic coronary CT angiography due to motion or high coronary calcium, and for optimal medical therapy non-responders.

Conclusions:

• The proposed diagnostic and management pathway appears safe and cost-effective.
• Further modeling is required to confirm the cost-effectiveness of the suggested approach.
• This strategy aims to optimize patient outcomes while managing healthcare costs.